跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BILAXTEN 20 mg COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BILAXTEN 20 mg COMPRIMIDOS
Approved
STANDARD
BILAXTEN 20 mg COMPRIMIDOS
Menarini International Operations Luxembourg S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2021
Approval ID
370a8981172b8e82
Company
Menarini International Operations Luxembourg S.A.
Type
Standard
Approval Details
Approval Id
370a8981172b8e82
Drug Cima Aemps Name
BILAXTEN 20 mg COMPRIMIDOS
Register Number
103763-16-11-2017
Holder Company Name
Menarini International Operations Luxembourg S.A.
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/menarini-international-operations-luxembourg-s-a
Authorization Date
2021-12-09
Dosage Form
COMPRIMIDO
Dose
20 mg / comprimido
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Menarini International Operations Luxembourg S.A.
Company Detail Path
/organization/menarini-international-operations-luxembourg-s-a
Company Information
Pharmaceutical Company Name
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.
Country Name
Luxembourg
City Name
luxembourg,country_lu
Address
Avenue de la Gare 1
Active Ingredients
BILASTINA
20 IP
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2021
Approval ID
370a8981172b8e82
Type
Standard
Back to CIMA-AEMPS Approvals